RenovoRx (RNXT) Cash from Operations (2024 - 2025)
RenovoRx (RNXT) has disclosed Cash from Operations for 2 consecutive years, with 3020000.0 as the latest value for Q4 2025.
- Quarterly Cash from Operations fell 24.28% to 3020000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 10973000.0 through Dec 2025, down 20.25% year-over-year, with the annual reading at 10973000.0 for FY2025, 20.25% down from the prior year.
- Cash from Operations hit 3020000.0 in Q4 2025 for RenovoRx, down from 2270000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 2194000.0 in Q3 2024 to a low of 3381000.0 in Q1 2025.